1. Home
  2. EXP vs LNTH Comparison

EXP vs LNTH Comparison

Compare EXP & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Materials Inc

EXP

Eagle Materials Inc

SELL

Current Price

$169.38

Market Cap

7.0B

Sector

Industrials

ML Signal

SELL

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

SELL

Current Price

$99.85

Market Cap

6.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EXP
LNTH
Founded
1963
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.5B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
EXP
LNTH
Price
$169.38
$99.85
Analyst Decision
Hold
Hold
Analyst Count
11
10
Target Price
★ $195.50
$106.99
AVG Volume (30 Days)
428.6K
★ 868.0K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 0.59%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 3.29
2.91
Revenue
★ $495,023,000.00
$343,374,000.00
Revenue This Year
$0.74
N/A
Revenue Next Year
$3.12
$12.19
P/E Ratio
$51.85
★ $34.36
Revenue Growth
N/A
★ 3.62
52 Week Low
$160.02
$50.16
52 Week High
$245.53
$111.86

Technical Indicators

Market Signals
Indicator
EXP
LNTH
Relative Strength Index (RSI) 40.62 44.06
Support Level N/A $98.81
Resistance Level $218.97 $100.40
Average True Range (ATR) 4.02 0.34
MACD 0.77 0.05
Stochastic Oscillator 54.33 55.50

Price Performance

Historical Comparison
EXP
LNTH

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: